Sms Pharmaceuticals Q2 Results
- BSE: 532815
- NSE: SMSPHARMA
- ISIN: INE812G01025
- Sector: Biotechnology & Drugs
BSE
235.05
-1.90 (-0.80%)
-1.90 (-0.80%)Volume1.42 K
Updated: Mon 14 Jul, 2025 | 11:09:09
NSE
235-2.15 (-0.91%)
-2.15 (-0.91%)Volume15.56 K
Updated: Mon 14 Jul, 2025 | 12:05:18
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Sms Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 24 | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 173.90 | 139.32 | 24.82% |
| Depreciation/ Amortization | 8.62 | 8.38 | 2.85% |
| Operating Income | 22.84 | 25.13 | -9.09% |
| Net Income | 14.10 | 16.48 | -14.44% |
| Other Operating Expenses Total | 9.67 | 7.90 | 22.44% |
| Net Income Before Taxes | 19.54 | 21.83 | -10.47% |
| Total Revenue | 196.75 | 164.45 | 19.64% |
| Selling/ General/ Admin Expenses Total | 17.93 | 16.88 | 6.17% |
| Diluted Normalized EPS | 1.67 | 1.95 | -14.36% |